Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients - a Bayesian network meta-analysis.

CONCLUSIONS: Baloxavir was significantly more effective than placebo regarding all outcomes except for the risk of pneumonia. Besides, baloxavir was associated with similar clinical efficacy and safety, and superior antiviral activity compared to other antivirals in HR patients, as well as in the entire population of uncomplicated patients with influenza. PMID: 33079575 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33079575?dopt=Abstract

Source: Current Medical Research and Opinion - October 22, 2020 Category: Research Tags: Curr Med Res Opin Source Type: research